JPRN-UMIN000007728已完成未知
Effect of Olmesartan on Endothelial Dysfunction After Everolimus Eluting Stent Implantation - Effect of Olmesartan on Endothelial Dysfunction After Everolimus Eluting Stent Implantation
Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine0 个研究点目标入组 60 人开始时间: 2012年4月11日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Recent myocardial infarction (within the previous 48 hours). 2. An ejection fraction of less than 40%. 3. An unprotected left main coronary artery disease. 4. A history of coronary artery vasospasm. 5. Severe calcified or adherence of thrombus in target vessel. 6. Bilateral renal artery stenosis or unilateral renal artery stenosis of remnant kidney. 7. Hyperkalemia (serum kalium>5.0mEq/L). 8. Renal insufficiency (serum creatinnin > 3.0 mg/dL). 9. Liver function disorder (AST or ALT > 100 U/L). 10. Expectant mother. 11. Inappropriate patients judged by the physician in charge.
研究者
相似试验
已完成
不适用
The effect of telmisartan on endothelial function in hypertensive patients.HypertensionJPRN-UMIN000005034Seigo Sugiyama20
已完成
不适用
Effect of valsartan on endothelial function, carotid intima-media thickness, left ventricular mass, arterial compliance, inflammation and coagulation abnormalities in the metabolic syndromeMetabolic syndromeNutritional, Metabolic, EndocrineISRCTN04503926Central Manchester and Manchester Children's Hospitals NHS Trust (UK)120
进行中（未招募）
不适用
Effect of Olmesartan Medoxomil on Vascular Markers in Hypertensive Patients with Metabolic Syndrome - VAMOSEUCTR2007-003130-41-DEDAIICHI-SANKYO EUROPE GmbH
已完成
不适用
OlmesaRtan Improvement endothelial functiON with hypertension studyJPRN-UMIN000015651Department of Cardiovascular Medicine, Kumamoto University Graduate School of Medical Sciences20
招募中
不适用
A clinical trial to find out the effect of Atorvastatin on dilatation of forearm blood vessel,in patients with Systemic Sclerosis.CTRI/2020/07/026894Intra Mural Research Fund